CARE vs AMTB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

CARE

51.2
AI Score
VS
AMTB Wins

AMTB

59.1
AI Score

Investment Advisor Scores

CARE

51score
Recommendation
HOLD

AMTB

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE AMTB Winner
Forward P/E 13.6612 11.4548 AMTB
PEG Ratio 0 0 Tie
Revenue Growth 68.3% -7.9% CARE
Earnings Growth 253.9% -3.6% CARE
Tradestie Score 51.2/100 59.1/100 AMTB
Profit Margin 44.9% 14.4% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: -2.7% · 3M: -7.4% AMTB 1M: +1.4% · 3M: +13.5%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $30.75

AMTB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 55

RSI (14): 54.8 · Price: $29.56

Fundamentals Snapshot

Metric CARE AMTB
Market Cap — —
Forward P/E 11.8 10.6
Trailing P/E 5.2 20.5
Revenue (TTM) — —
Revenue Growth 0.7% -0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.3%
EPS 5.89 1.43
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, AMTB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.